Biogen vs EUSA Pharma
Biogen
Innovative therapies worldwide for people living with serious neurological and neurodegenerative diseases
7823 employees · est. 1978 · Cambridge, United States
EUSA Pharma
Part of Recordati Rare Diseases, the business unit dedicated to rare diseases in the Recordati group
107 employees · est. 2006 · Hemel Hempstead, United King...
Biogen is the older company (1978 vs 2006); Biogen is the larger of the two.
Side-by-Side Comparison
| Metric | Biogen | EUSA Pharma |
|---|---|---|
| Founded | ||
| Founded | 1978 older | 2006 |
| Headquarters | ||
| Headquarters | Cambridge, United States | Hemel Hempstead, United Kingdom |
| Employees | ||
| Employees | 7823 larger | 107 |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biotechnology, Health Care, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | IPO | Venture round |
| Total Funding | ||
| Total Funding | $4.57M | $54.20M |
| Funding Rounds | ||
| Funding Rounds | 3 | 7 |
| Services | ||
| Services | Drug Development, Research and Development, Clinical Trials, Medicines Marketing, Corporate Responsibility Initiatives | Development of Medicines, Commercialization of Medicines, Healthcare Research, Pharmaceutical Manufacturing |
| Target Customers | ||
| Target Customers | Patients with Neurological Conditions, Patients with Immunological Conditions, Patients with Rare Diseases, Healthcare Professionals, Medical Researchers | Patients with Common Diseases, Patients with Rare Diseases, Investors, Healthcare Professionals |
| Taxonomy | ||
| Taxonomy | Neurological DisordersNeurodegenerative DiseasesInnovative TherapiesMultiple SclerosisBiological ProductsResearch And Development +5 | Rare DiseasesCancer TreatmentSpecialty PharmaceuticalsAdult And Pediatric CarePharmaceutical DevelopmentPharmaceutical Manufacturing +8 |
| Website | ||
| Website | biogen.com | eusapharma.com |
About Biogen
Biogen, founded in 1978, is a pioneering force in the biotechnology sector, with a particular focus on developing innovative therapies for serious neurological and neurodegenerative diseases. As indicated by their slogan, "Innovative therapies worldwide for people living with serious neurological an...
About EUSA Pharma
EUSA Pharma, a subsidiary of Recordati Rare Diseases, stands at the forefront of addressing critical gaps in adult and pediatric care for cancer and rare disease patients globally. Founded in 2006, this United Kingdom-based company operates within the Biotechnology, Health Care, and Pharmaceutical s...
Also comparing in this category
Comparing more than these two?
Get Biogen, EUSA Pharma and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does Biogen compare?
A PDF of Biogen and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Frequently Asked Questions
Compare Biogen with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Biogen on 9 Jun 2026, and EUSA Pharma on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
